This inventor holds 26 USPTO granted patents and 22 published patent applications, plus 4 CIPO patents and 18 EPO patents, primarily in Immunotherapy Antibodies. Top assignees: Genencor International, Inc., Abbvie Biotherapeutics Inc., Danisco US Inc.. Active years: 2001-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Santa Clara, CA (US) (2001 - 2016)
- Mountain View, CA (US) (2016 - 2020)
Company Filing History:
11 out of 422 
10 out of 52 
5 out of 485 
Years Active: 2001-2020
Areas of Expertise:
Title: **Fiona A Harding: Innovator in Therapeutic Antibodies**
Introduction
Fiona A Harding is a distinguished inventor based in Santa Clara, CA, recognized for her significant contributions to the field of biotherapeutics. With a remarkable portfolio of 26 patents, her work is pivotal in the development of innovative treatments leveraging antibody technology.
Latest Patents
Fiona's latest patents showcase her expertise in creating novel molecular solutions. One of her patents includes "Anti-PD-1 Antibodies and Their Uses," offering groundbreaking insights into new anti-PD-1 antibodies, compositions utilizing these antibodies, as well as the nucleic acids encoding them. Another notable patent is titled "Anti-OX40 Antibodies and Their Uses," which provides significant advancements through the introduction of novel anti-OX40 antibodies along with their applications, compositions, and methods for use.
Career Highlights
Throughout her career, Fiona A Harding has worked with renowned organizations such as Genencor International, Inc. and AbbVie Biotherapeutics, Inc. Her experience at these leading biopharmaceutical companies has equipped her with the expertise to drive innovations in antibody therapies effectively.
Collaborations
Collaboration is a key aspect of innovation, and Fiona has worked alongside esteemed colleagues such as David Aaron Estell and Yoshiko Akamatsu. These partnerships enhance her research and contribute to the successful development and commercialization of new biotherapeutic solutions.
Conclusion
Fiona A Harding’s impressive track record of patents and collaborations marks her as a leading figure in the biotechnology space. Her ongoing commitment to innovation in therapeutic antibodies will continue to influence the future of biomedicine positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile